Reckitt Benckiser Group (RKT) Stock Overview
Manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
RKT Community Fair Values
See what 91 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Reckitt Benckiser Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£44.87 |
| 52 Week High | UK£65.23 |
| 52 Week Low | UK£39.54 |
| Beta | 0.25 |
| 1 Month Change | -4.80% |
| 3 Month Change | -26.80% |
| 1 Year Change | -13.54% |
| 3 Year Change | -31.61% |
| 5 Year Change | -33.11% |
| Change since IPO | 533.46% |
Recent News & Updates
RKT: Future Returns Will Hinge On Dividend Growth And Share Buybacks
Reckitt Benckiser Group's analyst price target has been trimmed by about £1.32 per share, as analysts factor in softer revenue growth and profit margin assumptions alongside a slightly higher future P/E multiple. Analyst Commentary Recent research on Reckitt Benckiser points to a mixed set of views, with some analysts trimming price targets while others are upgrading their stance.RKT: Future Returns Will Hinge On Dividend And Capital Return Delivery
Analysts have trimmed the fair value estimate for Reckitt Benckiser Group from about £64.42 to £63.61, reflecting slightly softer revenue growth and profit margin assumptions, even as recent research includes both price target cuts and an upgrade on the shares. Analyst Commentary Recent Street research on Reckitt Benckiser Group has mixed signals, with some analysts trimming price targets while another has upgraded the shares, reflecting a balance of confidence in the franchise and caution around execution and earnings quality.RKT: Future Returns Will Hinge On Emerging Market Mix Execution
Analysts have trimmed the fair value estimate for Reckitt Benckiser Group to £64.42 from £65.63, reflecting recent price target cuts, such as Deutsche Bank's move to £54.60, and a reset of longer term earnings expectations linked to slightly softer revenue growth, a marginally lower profit margin outlook, and a reduced future P/E assumption to 19.99. Analyst Commentary Recent research on Reckitt Benckiser shows a mixed but useful range of views around valuation, execution and growth, with both bullish and bearish analysts adjusting their targets and ratings in response to company specific developments.We Think That There Are Some Issues For Reckitt Benckiser Group (LON:RKT) Beyond Its Promising Earnings
Reckitt Benckiser Group plc's ( LON:RKT ) stock didn't jump after it announced some healthy earnings. Our analysis...Recent updates
Shareholder Returns
| RKT | GB Household Products | GB Market | |
|---|---|---|---|
| 7D | -4.0% | -0.7% | -0.3% |
| 1Y | -13.5% | -8.3% | 18.4% |
Return vs Industry: RKT underperformed the UK Household Products industry which returned -8.3% over the past year.
Return vs Market: RKT underperformed the UK Market which returned 18.4% over the past year.
Price Volatility
| RKT volatility | |
|---|---|
| RKT Average Weekly Movement | 4.2% |
| Household Products Industry Average Movement | 4.3% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in GB Market | 11.8% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: RKT has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: RKT's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1819 | 36,200 | Kris Licht | www.reckitt.com |
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands.
Reckitt Benckiser Group plc Fundamentals Summary
| RKT fundamental statistics | |
|---|---|
| Market cap | UK£28.66b |
| Earnings (TTM) | UK£3.20b |
| Revenue (TTM) | UK£14.21b |
Is RKT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RKT income statement (TTM) | |
|---|---|
| Revenue | UK£14.21b |
| Cost of Revenue | UK£5.57b |
| Gross Profit | UK£8.63b |
| Other Expenses | UK£5.44b |
| Earnings | UK£3.20b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Jul 29, 2026
| Earnings per share (EPS) | 5.01 |
| Gross Margin | 60.78% |
| Net Profit Margin | 22.51% |
| Debt/Equity Ratio | 106.0% |
How did RKT perform over the long term?
See historical performance and comparisonDividends
Does RKT pay a reliable dividends?
See RKT dividend history and benchmarks| Reckitt Benckiser Group dividend dates | |
|---|---|
| Ex Dividend Date | Apr 09 2026 |
| Dividend Pay Date | Jun 12 2026 |
| Days until Ex dividend | 54 days |
| Days until Dividend pay date | 10 days |
Does RKT pay a reliable dividends?
See RKT dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/01 04:51 |
| End of Day Share Price | 2026/06/01 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Reckitt Benckiser Group plc is covered by 35 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Juan Rios Peris | Banco Santander |
| Iain Simpson | Barclays |
| Warren Ackerman | Barclays |